ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: CTI BioPharma Corp. (CTIC) Report Updated: May 20, 2017 | Print This Page

Get more stock ratings by Louis Navellier

CTI BioPharma Corp. (CTIC)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Biotechnology
Competitors: ASND,EXAS,CLVS,EXEL

Stock Analysis

Rating: Monthly View

A
B
C
D
F
May June July August September October November December January February March April

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

CTI BioPharma Corp.© quotemedia

Company Profile